Seeing Is Believing
LUMO is currently covered by 3 analysts with an average price target of $-5.05. This is a potential upside of $-9.39 (-216.36%) from yesterday's end of day stock price of $4.34.
Lumos Pharma's activity chart (see below) currently has 25 price targets and 33 ratings on display. The stock rating distribution of LUMO is 57.14% BUY and 42.86% HOLD.
Analysts average stock forecasts to be materialized ratio is 63.5% with an average time for these price targets to be met of 308 days.
Highest price target for LUMO is $13, Lowest price target is $4.25, average price target is $-5.05.
Most recent stock forecast was given by EDWARD WHITE from HCWAINWRIGHT on 08-Nov-2024. First documented stock forecast 10-May-2016.
Currently out of the existing stock ratings of LUMO, 4 are a BUY (57.14%), 3 are a HOLD (42.86%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$4.25
$-0.09 (-2.07%)
$4.25
3 months 14 days ago
(08-Nov-2024)
1/5 (20%)
$-0.11 (-2.52%)
148
Buy
$13
$8.66 (199.54%)
6 months 20 days ago
(02-Aug-2024)
0/1 (0%)
$11.13 (595.19%)
Buy
$10
$5.66 (130.41%)
$10
1 years 6 months ago
(22-Aug-2023)
1/4 (25%)
$7.03 (236.70%)
28
Hold
$7
$2.66 (61.29%)
$7
2 years 2 months 14 days ago
(08-Dec-2022)
2/4 (50%)
$2.8 (66.67%)
79
Buy
$26
2 years 3 months 8 days ago
(14-Nov-2022)
2/5 (40%)
$17.95 (222.98%)
182
What is LUMO (Lumos Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on LUMO (Lumos Pharma) with a proven track record?
Which analyst has the most public recommendations on LUMO (Lumos Pharma)?
Which analyst is the currently most bullish on LUMO (Lumos Pharma)?
Which analyst is the currently most reserved on LUMO (Lumos Pharma)?